Benztropine Mesylate
- Product NDC
- 0615-8223
- Requested package NDC
- 0615-8223-39
- 11-digit product format
- 006158223
- Labeler code
- 0615
- Product ID
- 0615-8223_c7b0eaab-bce7-4133-85e9-6ec282c63e7c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benztropine mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Application
- ANDA040715
- Marketing category
- ANDA
- Marketing start
- 2022-03-17
- Substance
- BENZTROPINE MESYLATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0615-8223 | 0615-8223-39 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040715-001 | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2007-08-27 | |
| A040715-002 | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2007-08-27 | |
| A040715-003 | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2007-08-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040715-001 | AA |
| A040715-002 | AA |
| A040715-003 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040715-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2007-08-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040715-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2007-08-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040715-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2007-08-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040715-001 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040715-002 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040715-003 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Benztropine Mesylate | BENZTROPINE MESYLATE | Unit Dose Solutions, Inc. | 53c02a89-012c-e724-e063-6294a90acc75 | 2026-06-08 | Warnings, Adverse reactions | 040715 ANDA040715 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Coupler LLC | 52bd605a-6a28-c2ec-e063-6294a90a8371 | 2026-05-26 | Warnings, Adverse reactions | 040715 ANDA040715 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Coupler LLC | 512ada3e-4b85-d989-e063-6394a90a9d54 | 2026-05-06 | Warnings, Adverse reactions | 040715 ANDA040715 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Coupler LLC | 5035534e-e15c-8f06-e063-6294a90a5003 | 2026-04-24 | Warnings, Adverse reactions | 040715 ANDA040715 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | NCS HealthCare of KY, LLC dba Vangard Labs | bac9dfb7-aa09-4841-9e8f-cc41bb438fe2 | 2026-04-15 | Warnings, Adverse reactions | 040715 ANDA040715 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | DIRECT RX | 9b93035b-34d6-4084-ba73-5dea72f9d124 | 2026-03-17 | Warnings, Adverse reactions | 040715 ANDA040715 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | NCS HealthCare of KY, LLC dba Vangard Labs | df0647b8-2aa7-4aa4-9ba3-82c28698e7c5 | 2026-01-23 | Warnings, Adverse reactions | 040715 ANDA040715 0615-8223-39 0615-8223 00615822339 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | American Health Packaging | b7f915a9-cd53-4a74-8ee5-35ee5c5c991e | 2025-11-18 | Warnings, Adverse reactions | 040715 ANDA040715 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Major Pharmaceuticals | 8b18b66c-2935-4304-8e20-ebf68dee5a1a | 2025-01-16 | Warnings, Adverse reactions | 040715 ANDA040715 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | A-S Medication Solutions | 53b134eb-b341-4fe4-a3ca-90a7da011974 | 2024-01-07 | Warnings, Adverse reactions | 040715 ANDA040715 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Bryant Ranch Prepack | 959363b8-6847-4f6e-9957-6254febb085c | 2023-05-30 | Warnings, Adverse reactions | 040715 ANDA040715 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Endo USA, Inc. | c19664aa-a797-4192-b5f3-e906a7cac048 | 2022-03-16 | Warnings, Adverse reactions | 040715 ANDA040715 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Benztropine Mesylate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BENZTROPINE MESYLATE | 1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WMJ8TL7510 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| df0647b8-2aa7-4aa4-9ba3-82c28698e7c5 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2961cf47-535c-c402-c24d-0a9130269674 | Product name | 3 | 20251121 |
| 3f930a8b-cc65-fba9-e4ca-58b6abcea16b | Product name | 2 | 20220509 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0615-8223-39 | Benztropine Mesylate | 30 in 1 BLISTER PACK | TABLET | 30 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 885219 | benztropine mesylate 0.5 MG Oral Tablet | PSN | df0647b8-2aa7-4aa4-9ba3-82c28698e7c5 | 10 |
| 885213 | benztropine mesylate 1 MG Oral Tablet | PSN | df0647b8-2aa7-4aa4-9ba3-82c28698e7c5 | 10 |
| 885219 | benztropine mesylate 0.5 MG Oral Tablet | SCD | df0647b8-2aa7-4aa4-9ba3-82c28698e7c5 | 10 |
| 885213 | benztropine mesylate 1 MG Oral Tablet | SCD | df0647b8-2aa7-4aa4-9ba3-82c28698e7c5 | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0615-8223-39 | 00615822339 | 30 TABLET in 1 BLISTER PACK (0615-8223-39) | 30 tablet | 2023-04-11 | No | No | Current |